Dow Ends Lower as Vaccine Rally Pauses

Optimism about a coronavirus vaccine fades with the reality that the pandemic continues to escalate in the U.S. and across the globe.
Author:
Publish date:

Stocks ended lower Tuesday as optimism about a coronavirus vaccine faded somewhat with the reality that the pandemic continues to escalate in the U.S. and across the globe.

The Dow Jones Industrial Average closed down 167 points, or 0.56%, at 29,783, and the S&P 500 declined 0.48% to 3,610. The Nasdaq finished down 0.21% at 11,899 after trading in and out of positive territory during the session.

In the Dow, Walgreens Boots Alliance  (WBA) - Get Report fell 9.6% after Amazon.com  (AMZN) - Get Report rolled out its digital pharmacy. Among the other drugstore chains, CVS  (CVS) - Get Report slumped 8.6% and Rite Aid  (RAD) - Get Report fell 16%.

The Dow and S&P 500 surged to record closing highs Monday after Moderna  (MRNA) - Get Report said its coronavirus vaccine candidate was 94.5% effective in a late-stage clinical trial. 

The Dow last set a record closing high on Feb. 12, just weeks before the coronavirus began spreading across the country.

That spread has been relentless so far this fall, with cases climbing in every state and hospitalizations from covid-19, the disease caused by the coronavirus, setting a record on Monday.

Many states across the country have implemented lockdowns again as they did in early spring to control the spread of the virus. 

California's indoor businesses were hit with new restrictions, while Iowa issued a limited mask mandate. Oregon, Washington and New Jersey also tightened restrictions.

Federal Reserve Chairman Jerome Powell said that while positive results from coronavirus vaccine trials were “certainly good news, particularly in the medium term, in the near term there are significant challenges and uncertainties. Even in the best case, widespread vaccination is months into the future.”

Retail sales in the U.S., meanwhile, rose at a slower-than-expected pace in October as spending slowed amid steady increases in weekly applications for unemployment benefits as the pandemic continued to accelerate.

"We just reached new highs, so it’s natural for the market to take a breather - and the slightly disappointing read on the retail sales front is facilitating that," said Chris Larkin, managing director of trading and investing product at E-Trade. 

"And without stimulus checks coming in, there’s a bit of uncertainty in this sector in the short term. That said, it’s still a positive read and so far retail earnings this week have painted a slightly different picture with Walmart and Home Depot knocking it out of the park," he added.

Walmart  (WMT) - Get Report posted stronger-than-expected third-quarter earnings with e-commerce activity boosting same-store sales at the world's biggest retailer.

U.S. same-store sales rose 6.4%, topping forecasts, "with strength across key categories, including general merchandise, health and wellness, and food," Walmart said. E-commerce sales surged 79%, adding around 5.7 percentage points to the overall comparable sales total.

The stock fell 2% to $149.33.

Walmart is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells the stock? Learn more now.

Home Depot's  (HD) - Get Report third-quarter earnings were better than expected and the world's largest home-improvement retailer said it plans to spend around $1 billion on bonuses and compensation increases for its frontline workers. 

Tesla  (TSLA) - Get Report rose 8.2% to $441.61 Tuesday following the announcement the electric-car maker will be added to the S&P 500 on Dec. 21.